Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Sanofi SA (NASDAQ:GCVRZ)

0.46
Delayed Data
As of Jan 20
 -0.011 / -2.34%
Today’s Change
0.08
Today|||52-Week Range
0.50
+21.05%
Year-to-Date
Regeneron Pharmaceuticals Could Be Ready to Rebound
Jan 20 / TheStreet.com - Paid Partner Content
The Zacks Analyst Blog Highlights: Clovis Oncology, Pfizer, Roche's, Sanofi and Regen...
Jan 10 / Zacks.com - Paid Partner Content
MannKind Has a New Plan, but Will It Work?
Jan 18 / MotleyFool.com - Paid Partner Content
Amgen Inks Multiple Deals, Offers Update on Repatha Lawsuit
Jan 10 / Zacks.com - Paid Partner Content
Sanofi Diabetes Drug Suliqua Wins EU Marketing Approval
Jan 18 / Zacks.com - Paid Partner Content
Biotech Resolutions: More Innovation, Better Execution, and Fewer Price Hikes
Jan 10 / MotleyFool.com - Paid Partner Content
Key FDA Events to Watch Out for in Q1
Jan 17 / Zacks.com - Paid Partner Content
The FDA Approved Fewer Drugs in 2016: Here's Why
Jan 09 / Zacks.com - Paid Partner Content
Sanofi, ImmuNext Ink Deal, Focus on Autoimmune Diseases
Jan 11 / Zacks.com - Paid Partner Content
Impax (IPXL) Applies for Generic Aubagio; Sanofi Files Lawsuit
Jan 09 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close0.47
Today’s open0.47
Day’s range0.43 - 0.47
Volume107,381
Average volume (3 months)571,372
Market cap--
Dividend yield--
Data as of 3:59pm ET, 01/20/2017

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratio--
Price/Sales--
Price/Book--

Competitors

No competitors data available.

Financials

Next reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)--
Annual profit (last year)--
Net profit margin--

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
No executives to display
Corporate headquarters
--, --

Forecasts


Search for Jobs